754
Participants
Start Date
December 31, 2016
Primary Completion Date
June 30, 2023
Study Completion Date
June 30, 2023
Bedaquiline
Delamanid
Clofazimine
Levofloxacin
Moxifloxacin
Linezolid
Pyrazinamide
Control arm MDR-TB regimen, consistent with WHO guidelines
Control arm MDR-TB regimen, consistent WHO guidelines
Centro de Investigación del Hospital Nacional Hipólito Unanue, Lima
Medecins Sans Frontieres Belgium, Khayelitsha
National Center for Tuberculosis and Lung Diseases, Tbilisi
Aundh Chest Hospital, Pune
National Center for Tuberculosis Problems, Almaty
Partners In Health Lesostho, Maseru
The Indus Hospital, Karachi
Institute of Chest Disease,, Kotri
Centro de Investigación de Enfermedades Neumológicas del Hospital Nacional Sergio Bernales, Lima
Hospital Nacional Dos de Mayo Parque Historia de la Medicina, Lima
City Centre of Phthisiopulmonology, Almaty
Center of Phthisiopulmonology of Almaty Health Department, Almaty
Collaborators (3)
Partners in Health
OTHER
Harvard Medical School (HMS and HSDM)
OTHER
Epicentre
OTHER
Institute of Tropical Medicine, Belgium
OTHER
Socios En Salud, Peru
UNKNOWN
Interactive Research and Development
OTHER
Médecins Sans Frontières, France
OTHER